Modalis Therapeutics Corp 4883.T-JP:Tokyo Stock Exchange

*Data is delayed | Exchange | JPY
Last | 9:33 AM JST
80.00UNCH (UNCH)
Volume
41,600
52 week range
76.00 - 336.00
Loading...
  • Open80.00
  • Day High80.00
  • Day Low78.00
  • Prev Close80.00
  • 52 Week High336.00
  • 52 Week High Date05/23/23
  • 52 Week Low76.00
  • 52 Week Low Date05/02/24

Key Stats

  • Market Cap17.29M
  • Shares Out33.36M
  • 10 Day Average Volume181,055.56
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-35.48

KEY STATS

  • Open80.00
  • Day High80.00
  • Day Low78.00
  • Prev Close80.00
  • 52 Week High336.00
  • 52 Week High Date05/23/23
  • 52 Week Low76.00
  • 52 Week Low Date05/02/24
  • Market Cap17.29M
  • Shares Out33.36M
  • 10 Day Average Volume181,055.56
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-35.48

RATIOS/PROFITABILITY

  • EPS (TTM)-67.50
  • P/E (TTM)-1.19
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Modalis Therapeutics Corp

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Modalis Therapeutics Corp is a Japan-based company engaged in the research and development of gene therapy drugs using the core platform CRISPR-GNDM technology. The Company develops gene therapy drugs that use CRISPR-GNDM technology, which is a unique platform technology, for genetic diseases caused by errors in the genetic code and epigenetics. The Company has two business models. Collaborative model pipeline opens CRISPR-GNDM technology to partners, and develops therapeutic...
Haru Morita
President, Chief Executive Officer, Founder, CEO of Subsidiary, Representative Director
Naoki Kobayashi
Chief Financial Officer, Vice President, Executive Officer
Address
4F
Y's Bldg., 16-5, Nihonbashi Kabuto-cho
Chuo-ku, TKY
103-0023
Japan